Your browser doesn't support javascript.
loading
Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans.
Panagiotou, Grigorios; Ghaly, Wael; Upadhyay, Jagriti; Pazaitou-Panayiotou, Kalliopi; Mantzoros, Christos S.
Afiliación
  • Panagiotou G; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
  • Ghaly W; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
  • Upadhyay J; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
  • Pazaitou-Panayiotou K; Department of Endocrinology-Endocrine Oncology, Theagenio Cancer Hospital, Thessaloniki 546 39, Greece.
  • Mantzoros CS; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Clin Endocrinol Metab ; 106(5): e2137-e2150, 2021 04 23.
Article en En | MEDLINE | ID: mdl-33493282

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Biomarcadores de Tumor / Adenocarcinoma Folicular / Folistatina / Cáncer Papilar Tiroideo Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Endocrinol Metab Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Biomarcadores de Tumor / Adenocarcinoma Folicular / Folistatina / Cáncer Papilar Tiroideo Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Endocrinol Metab Año: 2021 Tipo del documento: Article